Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
ORIGINAL ARTICLE
Year : 2020  |  Volume : 16  |  Issue : 71  |  Page : 486-492

Effect of diosgenin on T-helper 17 cells in mice with collagen-induced arthritis


1 Department of Immunology, Basic Medical Institute, Chengde Medical College, Chengde, China
2 Department of Anatomy, Basic Medical Institute, Chengde Medical College, Chengde, China
3 Department of Immunology, College of Lab Medicine, HeBei North University, Zhangjiakou, China
4 Department of Pathogen Biology, Basic Medical Institute, Chengde Medical College, Chengde, China
5 Department of Clinical Laboratory, The Affiliated Hospital of Chengde Medical College, Chengde, China
6 Department of Digestive System, The First Hospital of Shijiazhuang, Shijiazhuang, Hebei, China
7 Department of Obstetrics, The Maternal and Child Health Hospital of Shijiazhuang, Shijiazhuang, Hebei, China

Correspondence Address:
Hongru Song
Department of Immunology, College of Lab Medicine, HeBei North University, No. 11 South Diamond Road, High-Tech Zone, Zhangjiakou 075000, Hebei
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/pm.pm_426_19

Rights and Permissions

Background: Diosgenin, obtained from Dioscorea nipponica Makino, possesses anti-inflammatory properties. Objective: The objective of this study is to explore the therapeutic effects of diosgenin against collagen-induced arthritis (CIA) in DBA/1J mice. Materials and Methods: The CIA model was established using chicken type II collagen-immunized DBA1/J mice (0.1 mL/mouse), with the same stimulus repeated on day 21. Next, the CIA mouse model was selected, and inguinal lymph nodes were excised to obtain a single-cell suspension. Using CCK-8, control group, model group, and high-/medium-/low-dose diosgenin group were set based on drug toxicity. Next, the ratio of T-helper 17 cells (Th17) to CD3+ T cells was analyzed using flow cytometer. The levels of interleukin 17 (IL)-17 and IL-6 were determined by the enzyme-linked immunosorbent assay. The expression of RORγt was determined using the reverse-transcription quantitative real-time polymerase chain reaction and Western blot analysis. Results: An in vitro inhibitory rate of ≥ 70% was set as the cutoff value to select the high (25 μmol/L), medium (12.5 μmol/L), and low (6.25 μmol/L) doses of diosgenin. The Th17 cell ratio in CD3+ T cells, the levels of IL-17 and IL-6, and mRNA and protein expression of RORγt showed significantly increased tendency in the model group compared with the control group (P < 0.01 and/or P < 0.05). Diosgenin significantly decreased the Th17 cell ratio in CD3+ T cells, IL-17 and IL-6 levels, and RORγt expression when compared with the model group (P < 0.01 and/or P < 0.05). Conclusion: Diosgenin exhibited an antiarthritic effect in CIA mice by downregulating the differentiation of Th17 cells.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed378    
    Printed26    
    Emailed0    
    PDF Downloaded57    
    Comments [Add]    

Recommend this journal